Thomas DiRaimondo
Direttore Tecnico/Scientifico/R&S presso JANUX THERAPEUTICS, INC.
Patrimonio netto: 5 M $ in data 31/05/2024
Profilo
Thomas DiRaimondo is the founder of Sitari Pharma, Inc. (founded in 2013).
He is currently working as the Chief Scientific Officer at Janux Therapeutics, Inc. since 2018.
Dr. DiRaimondo has a doctorate degree from Stanford University and undergraduate and graduate degrees from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC.
0.20% | 02/01/2024 | 101 532 ( 0.20% ) | 5 M $ | 31/05/2024 |
Posizioni attive di Thomas DiRaimondo
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2018 |
Precedenti posizioni note di Thomas DiRaimondo
| Società | Posizione | Fine |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Fondatore | 01/08/2019 |
Formazione di Thomas DiRaimondo
| Stanford University | Doctorate Degree |
| University of Michigan | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Thomas DiRaimondo
